Dexmedetomidine (iX Biopharma)

N/A

Report date: 2024/04/08 17:08:30

Base Information

Drug NameDexmedetomidine (iX Biopharma)
Drug Alias NameIXB-120
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIx Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIx Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A